The Distribution of IgG Subclass Deposition on Renal Tissues from Patients with Anti-glomerular Basement Membrane Disease

Overview

Journal BMC Immunol

Publisher Biomed Central

Specialty Allergy & Immunology

Date 2013 Apr 17

PMID 23586976

Citations 22

Authors

Zhen Qu

Zhao Cui

Gang Liu

Ming-Hui Zhao

Affiliations

Soon will be listed here.

Abstract

Background: Renal injury of anti-glomerular basement membrane (GBM) disease is defined by the linear deposition of IgG along GBM and rapidly progressive glomerulonephritis. To date, the distribution of anti-GBM IgG subclasses on renal tissue is still unclear. In the current study, we investigated the deposition of the four IgG subclasses using immunohistochemistry in the renal biopsy specimens from 46 patients with anti-GBM disease.

Results: All four IgG subclasses can be detected within the GBM. Anti-GBM IgG3 was detected in all patients (100%), with 39 (84.8%) patients presenting with weak segmental staining and 7 (15.2%) patients with strong linear deposition. Anti-GBM IgG2 was detected in 22 (47.8%) patients, with 20 (90.9%) patients having weak segmental deposition and 2 (9.1%) patients presenting strong linear staining. Anti-GBM IgG1 and IgG4 were detected in 9 (19.6%) and 7 (15.2%) patients, respectively. IgG deposition along tubular basement membrane (TBM) was also detected in 31 (67.4%) patients. Among them, the IgG subclass distribution was similar to that of the deposition within the GBM: IgG1 6.5% (2/31), IgG2 45.2% (14/31), IgG3 100% (31/31) and IgG4 9.7% (3/31). We observed increased inflammatory cell infiltration into the interstitium in patients with increased anti-TBM IgG3 deposits (P=0.031).

Conclusions: Anti-GBM IgG3 predominantly deposits along GBM and TBM on renal biopsy specimens from patients with anti-GBM disease, which may be involved in the development of renal injury of the disease.

Citing Articles

Effective management of necrotizing crescentic glomerulonephritis using an aggressive combination therapy including avacopan in a patient double-seropositive for anti-GBM antibodies and ANCA: a case report.

Tanaka R, Toishi T, Masaki R, Aihara H, Sakamoto S, Ikeda M CEN Case Rep. 2024; .

PMID: 39254789 DOI: 10.1007/s13730-024-00929-4.

Coexistence of anti-glomerular basement membrane disease and IgA nephropathy: an illustrative case and comprehensive literature review.

Chen Z, Xu D, Cui F, Hou H, Mao Z, Gao X Ren Fail. 2024; 46(1):2323160.

PMID: 38466632 PMC: 10930099. DOI: 10.1080/0886022X.2024.2323160.

Anti-GBM disease with positive serum anti-GBM antibodies but negative IgG deposition: A case report.

Kazemzadeh K, Naeini E, Moeinzadeh F, Naimi A SAGE Open Med Case Rep. 2023; 11:2050313X231189767.

PMID: 37533486 PMC: 10392201. DOI: 10.1177/2050313X231189767.

Anti-glomerular Basement Membrane Disease After Diagnosis of Immunoglobulin A Nephropathy: A Case Report.

Matsuno T, Okumura T Cureus. 2023; 15(5):e39737.

PMID: 37398717 PMC: 10310401. DOI: 10.7759/cureus.39737.

Using imlifidase to elucidate the characteristics and importance of anti-GBM antibodies produced after start of treatment.

Tyrberg L, Andersson F, Uhlin F, Hellmark T, Segelmark M Nephrol Dial Transplant. 2023; 39(1):45-54.

PMID: 37385828 PMC: 10730795. DOI: 10.1093/ndt/gfad132.

References

Yan Y, Cui Z, Zhao M . [The distribution and clinical significance of IgG subclasses of anti-glomerular basement membrane antibodies]. Beijing Da Xue Xue Bao Yi Xue Ban. 2004; 36(5):501-4. View

Zhao J, Yan Y, Cui Z, Yang R, Zhao M . The immunoglobulin G subclass distribution of anti-GBM autoantibodies against rHalpha3(IV)NC1 is associated with disease severity. Hum Immunol. 2009; 70(6):425-9. DOI: 10.1016/j.humimm.2009.04.004. View

Pedchenko V, Bondar O, Fogo A, Vanacore R, Voziyan P, Kitching A . Molecular architecture of the Goodpasture autoantigen in anti-GBM nephritis. N Engl J Med. 2010; 363(4):343-54. PMC: 4144421. DOI: 10.1056/NEJMoa0910500. View

Kohda T, Okada S, Hayashi A, Kanzaki S, Ninomiya Y, Taki M . High nephritogenicity of monoclonal antibodies belonging to IgG2a and IgG2b subclasses in rat anti-GBM nephritis. Kidney Int. 2004; 66(1):177-86. DOI: 10.1111/j.1523-1755.2004.00719.x. View

Hart S, Jackson C, Kremmel L, McNeill M, Jersmann H, Alexander K . Specific binding of an antigen-antibody complex to apoptotic human neutrophils. Am J Pathol. 2003; 162(3):1011-8. PMC: 1868093. DOI: 10.1016/S0002-9440(10)63895-3. View

Wilson C, Dixon F . Anti-glomerular basement membrane antibody-induced glomerulonephritis. Kidney Int. 1973; 3(2):74-89. DOI: 10.1038/ki.1973.14. View

Papadea C, Check I . Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. Crit Rev Clin Lab Sci. 1989; 27(1):27-58. DOI: 10.3109/10408368909106589. View

Cattran D . Circulating anti-tubular basement membrane antibody in a variety of human renal diseases: detection and significance. Nephron. 1980; 26(1):13-9. DOI: 10.1159/000181943. View

Hopfer H, Maron R, Butzmann U, Helmchen U, Weiner H, Kalluri R . The importance of cell-mediated immunity in the course and severity of autoimmune anti-glomerular basement membrane disease in mice. FASEB J. 2003; 17(8):860-8. DOI: 10.1096/fj.02-0746com. View

10.

Kovalenko P, Fujinaka H, Yoshida Y, Kawamura H, Qu Z, El-Shemi A . Fc receptor-mediated accumulation of macrophages in crescentic glomerulonephritis induced by anti-glomerular basement membrane antibody administration in WKY rats. Int Immunol. 2004; 16(5):625-34. DOI: 10.1093/intimm/dxh058. View

11.

Zhou X, Lv J, Yu L, Cui Z, Zhao J, Yang R . FCGR2B gene polymorphism rather than FCGR2A, FCGR3A and FCGR3B is associated with anti-GBM disease in Chinese. Nephrol Dial Transplant. 2009; 25(1):97-101. DOI: 10.1093/ndt/gfp374. View

12.

Lerner R, Glassock R, Dixon F . The role of anti-glomerular basement membrane antibody in the pathogenesis of human glomerulonephritis. J Exp Med. 1967; 126(6):989-1004. PMC: 2138413. DOI: 10.1084/jem.126.6.989. View

13.

Hudson B, Tryggvason K, Sundaramoorthy M, Neilson E . Alport's syndrome, Goodpasture's syndrome, and type IV collagen. N Engl J Med. 2003; 348(25):2543-56. DOI: 10.1056/NEJMra022296. View

14.

MCPHAUL Jr J, MULLINS J . Glomerulonephritis mediated by antibody to glomerular basement membrane. Immunological, clinical, and histopathological characteristics. J Clin Invest. 1976; 57(2):351-61. PMC: 436659. DOI: 10.1172/JCI108286. View

15.

Zhou X, Lv J, Bu D, Yu L, Yang Y, Zhao J . Copy number variation of FCGR3A rather than FCGR3B and FCGR2B is associated with susceptibility to anti-GBM disease. Int Immunol. 2009; 22(1):45-51. DOI: 10.1093/intimm/dxp113. View

16.

Cui Z, Wang H, Zhao M . Natural autoantibodies against glomerular basement membrane exist in normal human sera. Kidney Int. 2006; 69(5):894-9. DOI: 10.1038/sj.ki.5000135. View

17.

Noel L, Aucouturier P, Monteiro R, PreudHomme J, Lesavre P . Glomerular and serum immunoglobulin G subclasses in membranous nephropathy and anti-glomerular basement membrane nephritis. Clin Immunol Immunopathol. 1988; 46(2):186-94. DOI: 10.1016/0090-1229(88)90181-x. View

18.

Bowman C, Ambrus K, Lockwood C . Restriction of human IgG subclass expression in the population of auto-antibodies to glomerular basement membrane. Clin Exp Immunol. 1987; 69(2):341-9. PMC: 1542418. View

19.

Radeke H, Sowa E, Chouchakova N, Skokowa J, Loscher F, Schmidt R . Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis. J Biol Chem. 2002; 277(30):27535-44. DOI: 10.1074/jbc.M200419200. View

20.

Cui Z, Zhao M, Segelmark M, Hellmark T . Natural autoantibodies to myeloperoxidase, proteinase 3, and the glomerular basement membrane are present in normal individuals. Kidney Int. 2010; 78(6):590-7. DOI: 10.1038/ki.2010.198. View